5160302025-10-012025-12-315160302025-12-315160302025-04-012025-12-315160302025-10-012025-12-31in-capmkt:OtherExpenses1Member5160302025-10-012025-12-31in-capmkt:OtherExpenses2Member5160302025-04-012025-12-31in-capmkt:OtherExpenses1Member5160302025-04-012025-12-31in-capmkt:OtherExpenses2Member5160302025-10-012025-12-31in-capmkt:ReportableSegments1Member5160302025-10-012025-12-31in-capmkt:ReportableSegments2Member5160302025-04-012025-12-31in-capmkt:ReportableSegments1Member5160302025-04-012025-12-31in-capmkt:ReportableSegments2Member5160302025-10-012025-12-31in-capmkt:ReportableSegments1Member5160302025-10-012025-12-31in-capmkt:ReportableSegments2Member5160302025-04-012025-12-31in-capmkt:ReportableSegments1Member5160302025-04-012025-12-31in-capmkt:ReportableSegments2Member5160302025-10-012025-12-31in-capmkt:ReportableSegments1Member5160302025-12-31in-capmkt:ReportableSegments1Member5160302025-10-012025-12-31in-capmkt:ReportableSegments2Member5160302025-12-31in-capmkt:ReportableSegments2Member5160302025-10-012025-12-31in-capmkt:ReportableSegments1Member5160302025-12-31in-capmkt:ReportableSegments1Member5160302025-10-012025-12-31in-capmkt:ReportableSegments2Member5160302025-12-31in-capmkt:ReportableSegments2Member5160302025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15160302025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25160302025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15160302025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares516030PAKKANOTLISTEDINE551D01018PAKKA LIMITEDMain BoardEquity2025-04-012026-03-312026-01-302025-12-30INRLakhsQuarterlyThird quarterMulti segment2026-01-3009:00:002026-01-3013:28:00Not applicable2025-10-012025-12-31UnauditedConsolidated9657520003192400099767600038739400045970000-336550001130910002288400041693000313499000890876000106800000010680000036043000036043000070757000000070757000474100075498000707570000754980000449481000101.571.3001.571.3Notes: <BR> <BR> 1) The above Unaudited Standalone Financial Results have been reviewed by the Audit Committee in its meeting held on 29th January, 2026 and approved by the Board of Directors at their meeting held on 30th January, 2026. The Statutory Auditors of the Company have carried out Limited Review of the aforesaid results. <BR> <BR> 2) These Financial Results have been prepared in accordance with the recognition and measurement principles of the Indian Accounting Standards( "Ind AS"), prescribed under section 133 of the Companies Act, 2013, read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. <BR> <BR> 3) In respect of the Company’s TSOP-2021, during the period ended 31st Decmeber 2025, <BR> a. During the period the company has extended TSOP-21 end date from December 31, 2026 to Decmber 31, 2031. <BR> b. During the quarter the company has issued the Tranche IV under the Pakka Stock option Plan, 2021 (TSOP 2021) comprising 1,24,500 ESOPS with an exercise proce of Rs.152.21 per options, vesting on 31 December 2026. <BR> <BR> 4) Pursuant to the assessment carried out by the Company in accordance with applicable Ind AS, the implementation of the Labour Codes has resulted in an estimated incremental impact of Rs.5.50 lakhs on the financial results on accounts of gratuity and leave encashment. The company continues to monitor the finalisation of central and state rules and additional imapct if any will be accounted as and when ascertained. <BR> <BR> 5)The plant was shut from 16th June, 2025 to 26th July, 2025 on account of expansion of production facility as part of Project Jagriti. <BR> <BR> 6)During the quarter, the Company approved the extension of the validity period of outstanding warrants from 12 months to 18 months. <BR> <BR> 7) The scheme of Merger of Pakka Impact Limited (CIN: U74110UP2014PLC062982), a wholly owned subsidiary company into Pakka Limited (CIN: L24231UP1981PLC005294) effective 1st April, 2025 has been approved by the Board of Directors in their meeting held on 30th May, 2025 in terms of the provisions of Section 230-232 of the Companies Act, 2013. The same is subject to regulatory approvals. Pending reciept of such approvals, the financial results do not include the effects of PIL's financials. The second motion application was heard by the Hon'ble NCLT, Allahbad Bench on 27 January 2026, and the matter is posted for final hearing and orders on 2 April 2026. <BR> <BR> 8) As per the Board approval, Pakka Pte Limited, a wholly owned subsidiary of the Company shall be closed in this Financial Year. Requisite provision for impairment has already been considered in the audited financials of FY 2023-24. <BR> <BR> 9) Figures of previous reporting periods have been regrouped wherever necessary to correspond with the figures of the current reporting period. <BR> <BR> 10) The results of the company are available on the company's website www.pakka.com, BSE website at www.bseindia.com and NSE website at www.nseindia.com.2025-04-012025-12-31UnauditedConsolidated25486650007595700026246220001027019000994250001946500031051400079231000124523000876247000253642400088198000088198000538240000538240000343740000000343740002408400058458000343740000584580000449481000100.770.77000.770.77Power and Fuel147697000Other Expenses165802000Power and Fuel361226000Other Expenses515021000Paper & Pulp829257000Moulded Products168419000Paper & Pulp2161043000Moulded Products4635790009976760002624622000009976760002624622000Paper & Pulp134508000Moulded Products-22648000Paper & Pulp143245000Moulded Products-393420001118600001039030000050600001570500010680000088198000Paper & Pulp8988279000Moulded Products185097000917337600046260009178002000Paper & Pulp3994163000Moulded Products352296000434645900025361300046000720001.The Company is engaged in the following business segments: <BR> - Paper & Pulp <BR> - Moulded Products <BR> 2. Segments have been identified taking into account the nature of activities and nature of risks and returns.remeasurements of defined benefit plans1371000Foreign Currency Transititon reserve37150005086000remeasurements of defined benefit plans-436000Foreign Currency Transititon reserve2441000023974000345000-11000000474100024084000